Stock Analysis

InnovAge Holding First Quarter 2025 Earnings: EPS Misses Expectations

NasdaqGS:INNV
Source: Shutterstock

InnovAge Holding (NASDAQ:INNV) First Quarter 2025 Results

Key Financial Results

  • Revenue: US$205.1m (up 12% from 1Q 2024).
  • Net loss: US$4.93m (loss narrowed by 52% from 1Q 2024).
  • US$0.036 loss per share (improved from US$0.076 loss in 1Q 2024).
earnings-and-revenue-growth
NasdaqGS:INNV Earnings and Revenue Growth November 10th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

InnovAge Holding EPS Misses Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 10%.

Looking ahead, revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 6.7% growth forecast for the Healthcare industry in the US.

Performance of the American Healthcare industry.

The company's shares are up 1.2% from a week ago.

Balance Sheet Analysis

Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We've done some analysis and you can see our take on InnovAge Holding's balance sheet.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.